Evidence-Based Oncology | May

Evidence-Based Oncology

UPMC Oncologists: Pioneers in the Clinical Pathways Movement
Signaling the Future of Personalized Medicine
Getting On Pathwayť?
Money Well Spent?
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
Getting Smarter in How We Score and Promote Value
Availability of Newer Agents May Lower Healthcare Costs
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology

More issues

Feature
$vacMongoViewPlus$